Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome

E Trojnar, K Erdelyi, C Matyas, S Zhao, J Paloczi… - Free Radical Biology …, 2020 - Elsevier
Study rationale Hepatorenal syndrome (HRS) is a life-threatening complication of end-stage
liver disease characterized by the rapid decline of kidney function. Herein, we explored the …
被引用次数：25 相关文章

Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome

E Trojnar, K Erdelyi, C Matyas… - … radical biology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Study rationale Hepatorenal syndrome (HRS) is a life-threatening complication of end-stage
liver disease characterized by the rapid decline of kidney function. Herein, we explored the …

Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome.

E Trojnar, K Erdelyi, C Matyas, S Zhao… - Free Radical Biology …, 2019 - europepmc.org
Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …